… /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: … Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously … & Communication jpatton@oncolytics.ca Investor Relations for Oncolytics Timothy McCarthy …

Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is acquiring Mitsubishi Tanabe Pharma Corporation in a multi-billion dollar deal that brings a portfolio of products marketed …

… Corp., a clinical-stage biotechnology company focused on revolutionizing treatments … gathering of institutional investors, venture capital firms, and biotech leaders, offering … : Sarcomatrix Therapeutics is a biotechnology company at the forefront of …

… . This follows a previous investigation in 2024, which found … not officially confirmed the investigation. China’s actions against … “unreliable entity” list. US biotech firm Illumina has also been … proceeds with the Apple investigation, it could escalate the …

… Close Share The Basel-based biotech company BioVersys made the first … shares. Focus on antibiotics The biotech company will thus generate proceeds … shares. The Glaxo Group had invested CHF3.5 million in the … good example of how a biotech company prefers an IPO …

… favorable regulatory environment provide Swiss investors a golden opportunity to … Artificial Intelligence (AI), cleantech, and biotech. Initiatives like Nirmata-ai Ventures … favorable regulatory environment provide Swiss investors a golden opportunity to …

Astex Pharmaceuticals has been celebrating a very successful first 25 years following a visit from Science minister Patrick Vallance last week. Astex Pharmaceuticals was formed in 1999 by current CEO Dr Harren Jhoti, Prof Sir Tom Blundell and Roberto …

… are worthy of further investigations to better understand this … valuable models for pathogenesis investigation of T2DM. Based on … individuals per group. To investigate effect of gut microbiota … DNA Stool Mini Kit (Tiangen Biotech Co., Ltd., China). Metagenome …

… describe it as a bad biotechnology investment climate,” Main said. “I would … well, and capital is flowing.” Biotech investment shows signs of improvement Industry … Ventures and T1D Fund. Longtime biotechnology investors are optimistic and see this …

… dominate the marine biotechnology market, with significant investments in research and … Germany, and France actively investing in marine biotechnology research. The European Union … , and India are investing heavily in marine biotechnology, with an emphasis …